257 related articles for article (PubMed ID: 8707954)
1. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
3. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Yagi H; Urakami S; Shirakawa H; Ishibe T
Eur Urol; 1996; 30(1):80-8. PubMed ID: 8854073
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
6. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
[TBL] [Abstract][Full Text] [Related]
7. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
Inagaki T; Ebisuno S; Uekado Y; Hirano A; Hiroi A; Shinka T; Ohkawa T
Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.
Li B; Kanamaru H; Noriki S; Yamaguchi T; Fukuda M; Okada K
Urol Res; 1998; 26(4):235-41. PubMed ID: 9759996
[TBL] [Abstract][Full Text] [Related]
10. Variable Bcl-2 phenotype in benign and malignant lesions of urothelium.
Bilim VN; Tomita Y; Kawasaki T; Takeda M; Takahashi K
Cancer Lett; 1998 Jun; 128(1):87-92. PubMed ID: 9652797
[TBL] [Abstract][Full Text] [Related]
11. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
[TBL] [Abstract][Full Text] [Related]
12. Biological characteristics of inverted papilloma of the urinary bladder.
Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
Br J Urol; 1996 Jan; 77(1):55-60. PubMed ID: 8653317
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
Uchida T; Minei S; Gao JP; Wang C; Satoh T; Baba S
Oncol Rep; 2002; 9(2):253-9. PubMed ID: 11836589
[TBL] [Abstract][Full Text] [Related]
14. p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder.
Asci R; Yildiz L; Sarikaya S; Buyukalpelli R; Yilmaz AF; Kandemir B
Urol Int; 2001; 67(1):34-40. PubMed ID: 11464113
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Kawai T; Torikata C; Aurues T; Ikeda T
Virchows Arch; 1998 May; 432(5):445-50. PubMed ID: 9645444
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzer.
Shiina H; Igawa M; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T
Oncology; 1996; 53(3):233-40. PubMed ID: 8643227
[TBL] [Abstract][Full Text] [Related]
18. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent event.
Lu QL; Laniado M; Abel PD; Stamp GW; Lalani EN
Mol Pathol; 1997 Feb; 50(1):28-33. PubMed ID: 9208811
[TBL] [Abstract][Full Text] [Related]
20. Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
Ogura K; Fukuzawa S; Habuchi T; Ogawa O; Yoshida O
Int J Urol; 1997 Nov; 4(6):561-6. PubMed ID: 9477184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
